Recent research published in Medical Oncology highlights drug repurposing as an innovative strategy to overcome traditional barriers in cancer therapy development. This approach leverages existing drugs to expedite oncological treatment options, bypassing lengthy development and high costs. These findings underscore a shift in oncology research aimed at enhancing therapeutic accessibility by optimizing currently approved medications.